Carbon tracking is a challenge in many industries, including the pharma sector. Companies are looking to manage their carbon emissions more effectively and meet their environmental, social and governance (ESG) goals, noted Maxence Cacheux, Zblocks co-founder and chief revenue officer. “They need to measure their internal carbon emissions (Scope 1), indirect emissions from the energy…
Qosina appoints former EssilorLuxottica exec as its EVP
Qosina announced today that it’s appointed Lee Pochter as its executive vice president. Pochter has more than 20 years of expertise in product strategy, business development, sales, marketing and supply chain management. Most recently, he was VP of the Alternative Lens Group at EssilorLuxottica. “I look forward to the guidance Lee will bring to our…
Cardinal Health, Palantir partner on AI for pharmaceutical products
Cardinal Health (NYSE:CAH) announced that it entered into a strategic collaboration with Palantir Technologies (NYSE:PLTR). The partnership pairs the companies to design a solution to give health systems and hospitals dynamic purchase decision insights. These insights help them quickly improve their bottom line. Dublin, Ohio-based Cardinal Health plans to integrate this solution into Foundry, Palantir’s…
Johnson & Johnson reports mixed Q4 results amid shaky economy
Johnson & Johnson (NYSE:JNJ) today reported Q4 results that beat The Street on earnings but missed on revenue amid continued macroeconomic challenges. The company’s Pharmaceutical business saw sales grow 6.8%. Pharma growth drivers included: Darzalex (daratumumab), a biologic for the treatment of multiple myeloma; Stelara (ustekinumab), a biologic for the treatment of a number of…
Agilent spends $725M to expand manufacturing
Agilent recently announced that it plans to double its manufacturing capacity of therapeutic nucleic acids. The $725 million investment will go toward the Santa Clara, California–based company’s Frederick, Colorado facility. The Colorado plant will get new Train C and D manufacturing lines. The facility already has a Train B manufacturing line, announced in 2020, that…
As Adderall shortage persists, many doctors are concerned
Supplies of the ADHD drug Adderall (amphetamine and dextroamphetamine) remain limited, forcing millions of patients to either search multiple pharmacies, ration their medication, seek alternatives or deal with withdrawal symptoms. Half of the physicians have directly witnessed the Adderall shortage in their practices, according to a recent Sermo survey of 348 physicians. Demand for Adderall is increasing.…
GE HealthCare investing $80M in contrast media ingredients plant in Norway
GE HealthCare today announced it is investing $80 million to expand contrast media production capacity in Norway. The investment will go toward increasing manufacturing capacity by 30% at its active pharmaceutical ingredients site in Lindesnes, Norway. As a result, the investment will create around 100 new jobs. GE HealthCare officials have committed to addressing the…
Cardinal Health beats The Street in Q1 — with pharma sales up 15%
Cardinal Health (NYSE: CAH) today reported first-quarter results that beat the consensus forecast on Wall Street, sticking by its full-year EPS guidance. The Dublin, Ohio–based pharma and medtech giant earned $110 million, or 40¢ per share, off $49.6 billion in revenue for the quarter ended Sept. 30, 2022. The bottom line was less than half…
Fujifilm establishing cell culture subsidiary in Korea
Fujifilm announced today that it is establishing a Seoul, South Korea–based subsidiary to accelerate its business growth in the cell culture media space. With paid-in capital of ₩300 million (roughly $250,000), the new subsidiary opens tomorrow. It will import cell culture media for bioproduction and advanced cell and gene therapies. Its goal through its direct…
Actylis launches with focus on raw materials and performance ingredients for life sciences and specialty chemicals
The conglomerate Actylis made its debut today. The new brand integrates specialty ingredient maker Aceto with 10 specialty ingredient manufacturing and sourcing companies. The Port Washington, New York–based company will serve customers in various industries, including pharmaceutical and biopharmaceutical companies. It will also offer materials to companies specializing in nutrition, cosmetics, agriculture and specialty chemicals markets.…